Filing Details
- Accession Number:
- 0001127602-24-003093
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-02 16:05:33
- Reporting Period:
- 2024-02-02
- Accepted Time:
- 2024-02-02 16:05:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 310158 | Merck & Co. Inc. | MRK | Pharmaceutical Preparations (2834) | 221918501 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1737231 | Jennifer Zachary | Merck &Amp; Co., Inc. 126 East Lincoln Avenue Rahway NJ 07065 | Evp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-02 | 19,417 | $87.10 | 78,557 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-02 | 49,499 | $126.97 | 29,058 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-02-02 | 19,417 | $0.00 | 19,417 | $87.10 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 38,835 | 2023-05-03 | 2032-05-02 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.8650 to $127.3000, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Holdings include shares acquired in dividend reinvestment transactions.
- The option vests and becomes exercisable in equal installments on 5/3/2023, 5/3/2024 and 5/3/2025.
Billionaire Hedge Funds
